Developmental GABAergic deficit enhances methamphetamine-induced apoptosis

Psychopharmacology

Volumn 215, Issue 3, 2011, Pages 413-427

  Abekawa, Tomohiro ^a   Ito, Koki ^a   Nakato, Yasuya ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Methamphetamine; Neurodegeneration; Neurodevelopment; PPI; Schizophrenia

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARVALBUMIN; 4 AMINOBUTYRIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; DIZOCILPINE MALEATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL DENSITY; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; GABAERGIC SYSTEM; INTERNEURON; MALE; MEDIAL PREFRONTAL CORTEX; NERVE DEGENERATION; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORY GATING; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SPRAGUE DAWLEY RAT; STARTLE REFLEX; TIME;

ANIMALS; APOPTOSIS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; IN SITU NICK-END LABELING; MALE; METHAMPHETAMINE; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SENSORY GATING; STARTLE REACTION; TIME FACTORS;

EID: 80052331597     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2269-5     Document Type: Article

References (65)

1. Abekawa T, Ohmori T, Ito K, Koyama T (2000) D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex. Brain Res 867: 250-254 (Pubitemid 30317405)
2. Abekawa T, Honda M, Ito K, Koyama T (2003) Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and α1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats. Psychopharmacology 169: 247-256 (Pubitemid 37255517)
3. Abekawa T, Ito K, Koyama T (2006) Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidineinduced acute increases in glutamate levels in the rat medial prefrontal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 374: 177-193 (Pubitemid 44819251)
4. Abekawa T, Ito K, Nakagawa S, Koyama T (2007) Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats. Psychopharmacology 192: 303-316 (Pubitemid 46701582)
5. Abekawa T, Ito K, Nakagawa S, Nakato Y, Koyama T (2008) Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex. Schizophr Res 101: 84-94
6. Alcantra S, Ferrer I, Soriano E (1993) Postnatal development of parvalbumin and calbindin D28K immunoreactivities in the cerebral cortex of rat. Anat Embryol (Berl) 188: 63-73 (Pubitemid 23271296)
7. Ali SF, Ahmad G, Slikker W Jr, Bondy SC (1989) Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain. Neurotoxicology 10: 383-392 (Pubitemid 20084625)
8. Arvanov VL, Liang X, Schwartz J, Grossman S, Wang RY (1997) Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J Pharmacol Exp Ther 283: 226-234 (Pubitemid 27438966)
9. Ault B, Miller MS, Kelly MD, Hildebrand LM, Earley WG, Luttinger D, Mallamo JP, Ward DJ (1995) WIN 63480, a hydrophilic TCPsite ligand, has reduced agonist-independent NMDA ion channel access compared to MK-801 and phencyclidine. Neuropharmacology 34: 1597-1606
10. Bakshi VP, Geyer MA (1998) Multiple limbic regions mediate the distribution of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18: 8394-8401 (Pubitemid 28465014)
11. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271: 787-794 (Pubitemid 24377766)
12. Ballok DA, Millward JM, Sakic B (2003) Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res 964: 200-210 (Pubitemid 36165144)
13. Belcher AM, O'Dell SJ, Marshall JF (2005) Impaired object recognition memory followingmethamphetamine, but not p-chloroamphetamineor d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30: 2026-2034 (Pubitemid 43102288)
14. Benes FM, Khan Y, Vincent SL (1992) Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain. Synapse 22: 338-349
15. Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S (2003) DNA fragmentation decreases in schizophrenia but not bipolar disorder. Arch Gen Psychiatry 60: 359-364 (Pubitemid 36402995)
16. Bertorello AM, Hopfield JF, Aperia A, Greengard P (1990) Inhibition by dopamine of (Na+ + K+) ATPase in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature 347: 386-388
17. Bower JF, Ali S (2006) High dose of methamphetamine that cause disruption of the blood-brain barrier in limbic region produce extensive neuronal degeneration in mouse hippocampus. Synapse 60: 521-532 (Pubitemid 44537085)
18. Buttner N, Bhattacharyya S, Walsh J, Benes FM (2007) DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res 93: 33-41 (Pubitemid 46817926)
19. Cadenhead KS, Geyer MA, Braff DL (1993) Impaired startle habituation and prepulse inhibition in patients with schizotypal personality disorder. Am J Psychiatry 150: 1862-1867 (Pubitemid 23356581)
20. Cadenhead KS, Swerdlow NR, Shafer K, Diaz M, Braff DL (2000) Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder. Evidence of inhibitory deficits. Am J Psychiatry 57: 1660-1668
21. Celio MR (1990) Calbindin and parvalbumin in the rat nervous system. Neuroscience 35: 375-475 (Pubitemid 20176750)
22. Daskalakis ZJ, Fitzgerald PB, Christensen BK (2007) The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res Rev 56: 427-442 (Pubitemid 350176600)
23. Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 36: 1-22 (Pubitemid 32763126)
24. Demeulemeester H, Vandesande F, Orban GA, Brando C (1988) Heterogeneity of GABAergic cells in cat visual cortex. J Neurosci 8: 988-1000 (Pubitemid 18085165)
25. Eichhammer P, Wiegand R, Kharraz A, Langguth B, Binder H, Hajak G (2004) Cortical excitability in neuroleptic-naïve first-episode schizophrenic patients. Schizophr Res 67: 253-259 (Pubitemid 38251456)
26. Farnbach-Pralong D, Bradbury R, Copolov D, Dean B (1998) Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors. Eur J Pharmacol 349: R7-R8 (Pubitemid 28277111)
27. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
28. Gizerian SS, Moy SS, Lieberman JA, Grobin AC (2006) Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activity. Psychopharmacology (Berl) 186: 334-342 (Pubitemid 43800835)
29. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF (2006) Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 81: 47-63 (Pubitemid 41817206)
30. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129: 79-84 (Pubitemid 27037454)
31. Hetts SW (1998) To die or not to die: an overview of apoptosis and its role in disease. JAMA 279: 300-307 (Pubitemid 28071022)
32. Hollman M, Heinemann S (1994) Cloned glutamate receptors. Ann Rev Neurosci 17: 31-108 (Pubitemid 24117025)
33. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27: 11496-11500 (Pubitemid 350006886)
34. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74 (Pubitemid 29044848)
35. Ito K, Abekawa T, Koyama T (2006) Valproate blocks high-dose methamphetamine- induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine. Psychopharmacology 186: 525-533 (Pubitemid 43855839)
36. Japha K, Koch M (1999) Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol. Psychopharmacology (Berl) 144: 347-354 (Pubitemid 29307259)
37. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH (2004) Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry 161: 109-115 (Pubitemid 38419315)
38. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA (2005) Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuro Psychopharmacol Biol Psychiatry 29: 846-858 (Pubitemid 40897803)
39. Javitt DC, Frusciante M (1997) Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse. Psychopharmacology (Berl) 129: 96-98 (Pubitemid 27037457)
40. Joo JY, Kim BW, Lee JS, Park JY, Kim S, Yun YJ, Lee SH, Lee SH, Rhim H, Son H (2007) Activation of NMDA receptors increases proliferation and differentiation of hippocampal neural progenitor cells. J Cell Sci 120: 1358-1370 (Pubitemid 46780029)
41. Kadota T, Kadota K (2004) Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine. Arch Histol Cytol 67: 241-251 (Pubitemid 39612257)
42. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, Yugelun-Todd D, Kikinis R, Jolesz FA, McCarley RW (2003) Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 160: 56-164
43. Korada S, Zheng W, Basillico C, Schwartz ML, Vaccarino FM (2002) Fibroblast growth factor 2 is necessary for the growth of glutamate projection in neurons in the anterior neocortex. J Neurosci 22: 863-875 (Pubitemid 34141767)
44. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 169: 215-233 (Pubitemid 37264943)
45. Kumari V, Sharma T (2002) Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology 162: 97-101 (Pubitemid 34743949)
46. Kumari V, Soni W, Sharma T (1999) Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156: 1046-1051 (Pubitemid 29302798)
47. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo T-SW (1999) Altered GABA transmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 46: 616-626 (Pubitemid 29401859)
48. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100: 8987-8992 (Pubitemid 36899210)
49. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 2: 529-540 (Pubitemid 24100885)
50. Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I (2006) Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143: 51-62 (Pubitemid 44667305)
51. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 3rd edn. Academic, USA
52. Reynolds GP, Beasley CL (2001) GABAergic neuronal subtypes in the human frontal cortex-development and deficits in schizophrenia. J Chem Neuroanat 22: 95-100 (Pubitemid 32695512)
53. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396: 157-198 (Pubitemid 16100809)
54. Sadikot AF, Burhan AM, Belanger MC, Sasseville R (1998) NMDA receptor antagonist influences early development of GABAergic interneurons in the mammalian striatum. Dev Brain Res 105: 35-42 (Pubitemid 28068130)
55. Schotte A, Janssen PF, Megens AA, Lysen JE (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631: 191-201
56. Selemon LD, Begovic A, Goldman-Rakic PS, Castner SA (2006) Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate. Neuropharmacology 32: 919-931 (Pubitemid 46426180)
57. Shin DM, Korada S, Raballo R, Shashikant CS, Simeone A, Taylor JR, Vaccarino F (2004) Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J Neurosci 24: 2247-2258 (Pubitemid 38314556)
58. Sills TL (1999) Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window. Brain Res Bull 48: 445-448 (Pubitemid 29234861)
59. Solbach S, Celio MR (1997) Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat Embryol 184: 103-124
60. Swerdlow NR, Bakshi VP, Geyer MA (1996) Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 279: 1290-1299 (Pubitemid 27166777)
61. Van Haren NEM, Hulshoff Pol HE, Schnack HG (2007) Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 32: 2057-2066 (Pubitemid 47417696)
62. Wang CZ, Yang SF, Xia Y, Johnson KM (2008) Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology 33: 2442-2455
63. Wolf ME, Xue C-J, Li Y, Wavak D (2000) Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species. J Neurochem 75: 1634-1644
64. Woods BT (1998) Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 155: 1661-1670 (Pubitemid 28547488)
65. Yoneyama M, Nakamichi N, Fukui M, Kitayama T, Georgiev DD, Makanga JO, Nakamura N, Taniura H, Yoneda Y (2008) Promotion of neuronal differentiation through activation of N-methyl-D-aspartate receptors transiently expressed by undifferentiated neural progenitor cells in fetal rat neocortex. J Neurosci Res 86: 2392-2402